NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Precision Neuroscience

Precision Neuroscience

Private
New York City, New YorkHealthcare & Life Scienceshttps://precisionneuro.io/

Last Round

VC Round

Nov 5, 2025

Est. Valuation

$520M

Total Funding Raised

$155M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Precision Neuroscience is a neurotechnology company that develops minimally invasive brain-computer interface technology aimed at delivering effective treatments for patients with neurological disorders by facilitating direct connections between the human brain and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

brain-computer interfaceBCIbrain chipneural implantminimally invasive BCIneural signal processingcortical interfaceneural decodingmedical deviceneurotechnologybrain-machine interfaceBMIneural engineeringbioelectronicsneural interface

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Precision Neuroscience Comparables

Compare Precision Neuroscience with similar companies based on industry and business-model similarity.

Precision Neuroscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Synchron
88%
INBRAIN Neuroelectronics
83%
Paradromics
83%

Precision Neuroscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 5, 2025
Series CDec 16, 2024
Series BJan 25, 2023
Series AMay 25, 2021

Key People

Founding team and executive leadership

Benjamin Rapoport

Co-Founder And Chief Science Officer

Founding Team

Michael Mager

Co-Founder And Chief Executive Officer

Founding Team

Craig Mermel

President And Chief Product Officer

Executive Team

Nathan Pletcher

Chief Technology Officer

Executive Team

Precision Neuroscience Investors

Notable investors and investment history

Precision Neuroscience investors
InvestorRounds
Forepont Capital PartnersSeries B
Steadview CapitalSeries B, Series C, Series A
SCI VenturesVC Round
B Capital GroupSeries B, Series C, Series A
Duquesne Family OfficeSeries C
re.Mind CapitalSeries B
General Equity HoldingsSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2026

    Monthly visitors increased 81% MoM, reaching 23K.

  • Mar 4, 2026

    First product, the Layer 7 brain-computer interface, has begun human trials.

Precision Neuroscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Precision Neuroscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Precision Neuroscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range122
Year Founded2021
Last FundingNov 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.